Cargando…

Suramin Disturbs the Association of the N-Terminal Domain of SARS-CoV-2 Nucleocapsid Protein with RNA

Suramin was originally used as an antiparasitic drug in clinics. Here, we demonstrate that suramin can bind to the N-terminal domain of SARS-CoV-2 nucleocapsid protein (N-NTD) and disturb its interaction with RNA. The BLI experiments showed that N-NTD interacts suramin with a dissociate constant (K(...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Chenyun, Xu, Hao, Li, Xiao, Yu, Jiaxin, Lin, Donghai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051649/ https://www.ncbi.nlm.nih.gov/pubmed/36985506 http://dx.doi.org/10.3390/molecules28062534

Ejemplares similares

Suramin inhibits SARS-CoV-2 nucleocapsid phosphoprotein genome packaging function
por: Boniardi, Irene, et al.
Publicado: (2023)

Thermostability of the N-Terminal RNA-Binding Domain of the SARS-CoV Nucleocapsid Protein: Experiments and Numerical Simulations
por: Fang, Huey-Jen, et al.
Publicado: (2009)

Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein
por: Zhou, Renjie, et al.
Publicado: (2020)

Antiviral drug design based on structural insights into the N-terminal domain and C-terminal domain of the SARS-CoV-2 nucleocapsid protein
por: Luan, Xiaodong, et al.
Publicado: (2022)

Characterizing nucleic acid interactions with the N-Terminal binding domain of the SARS-CoV-2 nucleocapsid protein
por: Cubuk, Jasmine, et al.
Publicado: (2022)

Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein
por: Khan, Abbas, et al.
Publicado: (2020)

Insights into the specificity for the interaction of the promiscuous SARS-CoV-2 nucleocapsid protein N-terminal domain with deoxyribonucleic acids
por: Caruso, Icaro Putinhon, et al.
Publicado: (2022)

Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses
por: Wen, Yingfen, et al.
Publicado: (2023)

The Inherent Dynamics and Interaction Sites of the SARS-CoV-2 Nucleocapsid N-Terminal Region
por: Redzic, Jasmina S., et al.
Publicado: (2021)

Suramin Targets the Conserved Ligand-Binding Pocket of Human Raf1 Kinase Inhibitory Protein
por: Guo, Chenyun, et al.
Publicado: (2021)

The C-Terminal Portion of the Nucleocapsid Protein Demonstrates SARS-CoV Antigenicity
por: Liu, Guozhen, et al.
Publicado: (2003)

Letter to the Editor: (1)H, (13)C, and (15)N resonance assignments of the N-terminal domain of the SARS CoV nucleocapsid protein
por: Zhong, Nan, et al.
Publicado: (2005)

Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain
por: Wu, Chao, et al.
Publicado: (2021)

Modular characterization of SARS-CoV-2 nucleocapsid protein domain functions in nucleocapsid-like assembly
por: Wang, Yan, et al.
Publicado: (2023)

The Epitope Study on the SARS-CoV Nucleocapsid Protein
por: Li, Shuting, et al.
Publicado: (2003)

(1)H, (13)C, and (15)N backbone chemical shift assignments of the C-terminal dimerization domain of SARS-CoV-2 nucleocapsid protein
por: Korn, Sophie M., et al.
Publicado: (2020)

Domain-specific biochemical and serological characterization of SARS-CoV-2 nucleocapsid protein
por: Wu, Chao, et al.
Publicado: (2021)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
por: Guo, Wenhan, et al.
Publicado: (2021)

Dual functions of the SARS-CoV-2 nucleocapsid domains mediate RNA binding and phase separation
por: Estelle, Aidan B., et al.
Publicado: (2023)

Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle
por: Salgado-Benvindo, Clarisse, et al.
Publicado: (2020)

The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CL(pro) In Vitro
por: Eberle, Raphael J., et al.
Publicado: (2021)

Structural Basis for SARS-CoV-2 Nucleocapsid Protein Recognition by Single-Domain Antibodies
por: Ye, Qiaozhen, et al.
Publicado: (2021)

Structural basis for SARS-CoV-2 Nucleocapsid protein recognition by single-domain antibodies
por: Ye, Qiaozhen, et al.
Publicado: (2021)

Low complexity domains of the nucleocapsid protein of SARS-CoV-2 form amyloid fibrils
por: Tayeb-Fligelman, Einav, et al.
Publicado: (2023)

Biochemical characterization of SARS-CoV-2 nucleocapsid protein
por: Zeng, Weihong, et al.
Publicado: (2020)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

DNA Folding by the SARS-CoV-2 Nucleocapsid Protein
por: Choi, Youna N., et al.
Publicado: (2021)

Dynamics of the SARS-CoV-2 nucleoprotein N-terminal domain triggers RNA duplex destabilization
por: Caruso, Ícaro P., et al.
Publicado: (2021)

An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
por: Suryadevara, Naveenchandra, et al.
Publicado: (2022)

Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences
por: Yang, Mei, et al.
Publicado: (2021)

Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein
por: Dinesh, Dhurvas Chandrasekaran, et al.
Publicado: (2020)

SARS-CoV-2 Nsp8 N-terminal domain folds autonomously and binds dsRNA
por: Treviño, Miguel Á, et al.
Publicado: (2023)

SARS-CoV-2 nucleocapsid protein inhibits the PKR-mediated integrated stress response through RNA-binding domain N2b
por: Aloise, Chiara, et al.
Publicado: (2023)

Detection of breastmilk antibodies targeting SARS-CoV-2 nucleocapsid, spike and receptor-binding-domain antigens
por: Favara, D. M., et al.
Publicado: (2020)

Glycogen Synthase Kinase-3 Interaction Domain Enhances Phosphorylation of SARS-CoV-2 Nucleocapsid Protein
por: Yun, Jun Seop, et al.
Publicado: (2022)

Structural domains of SARS-CoV-2 nucleocapsid protein coordinate to compact long nucleic acid substrates
por: Morse, Michael, et al.
Publicado: (2022)

Architecture and self‐assembly of the SARS‐CoV‐2 nucleocapsid protein
por: Ye, Qiaozhen, et al.
Publicado: (2020)

Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
por: Terry, James S., et al.
Publicado: (2020)

The SARS-CoV nucleocapsid protein: A protein with multifarious activities
por: Surjit, Milan, et al.
Publicado: (2008)

Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein
por: Ye, Qiaozhen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pdcab705kef6b5eisvbntufv2i